Concepedia

Author

Kaoru Kubota

National Cancer Center Hospital EastORCID

Also Known As

Gautschi, Oliver, K Kubota, K. KUBOTA, K. Kubota, KAORU KUBOTA, Kaoru KUBOTA, Kaoru Kubota, Masahiro Seike, Rintaro Noro, Sewanti Limaye

437

Publications

32.1K

Citations

61

H-Index

130

Concepts

All Affiliations

National Cancer Center Hospital EastNippon Medical SchoolYokohama Municipal Citizen's HospitalNippon Medical School HospitalCancer Research And Biostatistics
KK

About

Kaoru Kubota is an author at National Cancer Center Hospital East specializing in medicine, oncology, and lung cancer.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

40

88

11.5K

2

Health Sciences

19

32

1.4K

3

Business

1

1

52

4

Engineering

1

1

52

5

Nursing

1

1

33

Kaoru Kubota

×

169

Publications

26.7K

Citations

56

H-Index

YearCitations

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

Peter Goldstraw, Kari Chansky, John Crowley,

Journal of Thoracic Oncology

2016

4.5K

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Scott Antonia, Augusto Villegas, Davey B. Daniel,

New England Journal of Medicine

2017

4.4K

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok, Yi‐Long Wu, Iveta Kudaba,

The Lancet

2019

3.2K

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

Scott Antonia, Augusto Villegas, Davey B. Daniel,

New England Journal of Medicine

2018

2.7K

Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan

Yuichiro Ohe, Yasuo Ohashi, Kaoru Kubota,

Annals of Oncology

2006

635

Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study

Marina Chiara Garassino, Byoung Chul Cho, Joo-Hang Kim,

The Lancet Oncology

2018

568

The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer

Kari Chansky, Frank Detterbeck, Andrew G. Nicholson,

Journal of Thoracic Oncology

2017

495

The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell Lung Cancer in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer

Andrew G. Nicholson, Kari Chansky, John Crowley,

Journal of Thoracic Oncology

2015

412

Predominant infiltration of macrophages and CD8<sup>+</sup> T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer

Osamu Kawai, Genichiro Ishii, Kaoru Kubota,

Cancer

2008

382

Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03

Satoshi Teramukai, Toshiyuki Kitano, Yusuke Kishida,

European Journal of Cancer

2009

339

Page 1